Amalia A. van Everdingen

Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Amalia A. van Everdingen, Johannes W. G. Jacobs, Dirk R. Siewertsz van Reesema et al. · Annals of Internal Medicine · 2002 · 483 citations

Followup radiographic data on patients with rheumatoid arthritis who participated in a two‐year trial of prednisone therapy or placebo

Johannes W. G. Jacobs, Amalia A. van Everdingen, Suzanne Verstappen et al. · Arthritis & Rheumatism · 2006 · 82 citations

Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.

H. R. Van Den Brink, Amalia A. van Everdingen, Marja J. van Wijk et al. · Annals of the Rheumatic Diseases · 1993 · 57 citations · Full text

Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?

Amalia A. van Everdingen, Dirk R. Siewertsz van Reesema, Johannes W G Jacobs et al. · PubMed · 2003 · 55 citations

Bone Disease, Rheumatology, Spinal Cord Injury +15

Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.

H. R. Van Den Brink, Willem F. Lems, Amalia A. van Everdingen et al. · Annals of the Rheumatic Diseases · 1993 · 42 citations · Full text